Skip to main content
Clinical Trials/JPRN-UMIN000033284
JPRN-UMIN000033284
Completed
未知

Multicenter prospective trial of transbronchial cryobiopsy to evaluate its safety and utility - Multicenter prospective trial of transbronchial cryobiopsy

Japanese Red Cross Medical Center0 sites110 target enrollmentJuly 4, 2018

Overview

Phase
未知
Intervention
Not specified
Conditions
Diffuse interstitial lung disease (interstitial pneumonia, idiopathic pulmonary fibrosis, chronic hypersensitivity pneumonitis, sarcoidosis), malignant tumor (lung cancer, mesothelioma, metastatic lung carcinoma), respiratory infectious disease (tuberculosis, nontuberculosis mycobacterial infection, pulmonary aspergillosis), other diseases
Sponsor
Japanese Red Cross Medical Center
Enrollment
110
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 4, 2018
End Date
August 16, 2019
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\) Patients are excluded if they have past history of severe allergy to sedative drugs (lidocaine, midazolam, pethidine and so on) 2\) Patients are excluded if they are suspected to have tendency of bleeding from cryobiopsy lesion because of aneurysm of bronchoartery and lung metastasis of renal cell carcinoma and so on. 3\) Patients are excluded if they can't stop anticoagulation therapy. 4\) Patients are excluded if they have uncontrolled comlication such as unstable angina, acute myocardial infarction, heart failure and severe bronchial asthma attack. 5\) Patients are excluded if they are pregnant. 6\) Patients are excluded if their doctor decide not to include.

Outcomes

Primary Outcomes

Not specified

Similar Trials